If nicotine is a developmental neurotoxicant in animal studies, dare we recommend nicotine replacement therapy in pregnant women and adolescents?

Neurotoxicology and Teratology

Volumn 30, Issue 1, 2008, Pages 1-19

  Slotkin, Theodore A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adolescence; Brain development; Nicotine; Nicotine replacement therapy; Pregnancy; Smoking; Tobacco

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ADOLESCENCE; ADOLESCENT; ADOLESCENT PREGNANCY; APOPTOSIS; BRAIN DEVELOPMENT; BRAIN REGION; CELL PROLIFERATION; CHOLINERGIC TRANSMISSION; CIGARETTE SMOKING; COGNITIVE THERAPY; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG SAFETY; FEMALE; HUMAN; MATERNAL SMOKING; NERVE CELL; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NERVOUS SYSTEM DEVELOPMENT; NEUROTOXICITY; NICOTINE REPLACEMENT THERAPY; NONHUMAN; OSMOTIC MINIPUMP; PREGNANCY; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REINFORCEMENT; REVIEW; REWARD; SMOKING CESSATION; SYNAPSE; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; NICOTINE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; SUBSTANCE-RELATED DISORDERS;

ANIMALIA; NICOTIANA TABACUM;

EID: 38349105305     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2007.09.002     Document Type: Review

References (255)

1. Abreu-Villaça Y., Seidler F.J., and Slotkin T.A. Impact of adolescent nicotine exposure on adenylyl cyclase-mediated cell signaling: enzyme induction, neurotransmitter-specific effects, regional selectivities, and the role of withdrawal. Brain Res. 988 (2003) 164-172
2. Abreu-Villaça Y., Seidler F.J., Tate C.A., and Slotkin T.A. Nicotine is a neurotoxin in the adolescent brain: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations. Brain Res. 979 (2003) 114-128
3. Abreu-Villaça Y., Seidler F.J., Qiao D., Tate C.A., Cousins M.M., Thillai I., and Slotkin T.A. Short-term adolescent nicotine exposure has immediate and persistent effects on cholinergic systems: critical periods, patterns of exposure, dose thresholds. Neuropsychopharmacology 28 (2003) 1935-1949
4. Abreu-Villaça Y., Seidler F.J., and Slotkin T.A. Does prenatal nicotine sensitize the brain to nicotine-induced neurotoxicity in adolescence?. Neuropsychopharmacology 29 (2004) 1440-1450
5. Abreu-Villaça Y., Seidler F.J., Tate C.A., Cousins M.M., and Slotkin T.A. Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal. Neuropsychopharmacology 29 (2004) 879-890
6. Action on Smoking and Health, Guidance for health professionals on changes in the licensing arrangements for nicotine replacement therapy, 2005: Available: http://ash.org.uk/html/cessation/Smoking%20reduction/NRT051229.pdf [accessed 15 June 2007.
7. Adgent M.A. Environmental tobacco smoke and sudden infant death syndrome: a review. Neuropsychopharmacology 77 (2006) 69-85
8. Adriani W., Macri S., Pacifici R., and Laviola G. Restricted daily access to water and voluntary nicotine oral consumption in mice: methodological issues and individual differences. Behav. Brain Res. 134 (2002) 21-30
9. Adriani W., Spijker S., Deroche-Gamonet V., Laviola G., Le Moal M., Smit A.B., and Piazza P.V. Evidence for enhanced neurobehavioral vulnerability to nicotine during periadolescence in rats. J. Neurosci. 23 (2003) 4712-4716
10. Atluri P., Fleck M.W., Shen Q., Mah S.J., Stadfelt D., Barnes W., Goderie S.K., Temple S., and Schneider A.S. Functional nicotinic acetylcholine receptor expression in stem and progenitor cells of the early embryonic mouse cerebral cortex. Dev. Biol. 240 (2001) 143-156
11. Bardy A.H., Seppala T., Lillsunde P., Kataja J.M., Koskela P., Pikkarainen J., and Hiilesmaa V.K. Objectively measured tobacco exposure during pregnancy: neonatal effects and relation to maternal smoking. Br. J. Obstet. Gynaecol. 100 (1993) 721-726
12. Barnes C.D., and Eltherington L.G. Drug Dosage in Laboratory Animals: A Handbook (Revised Edition) (1973), Univ. of California Press, Berkeley, CA
13. Barron J., Petrilli F., Strath L., and McCaffrey R. Successful interventions for smoking cessation in pregnancy. Am. J. Matern. Child Nursing 32 (2007) 42-47
14. Basta P.V., Basham K.B., Ross W.P., Brust M.E., and Navarro H.A. Gestational nicotine exposure alone or in combination with ethanol down-modulates offspring immune function. Int. J. Immunopharmacol. 22 (2000) 159-169
15. Bauman K.E., Foshee V.A., Linzer M.A., and Koch G.G. Effect of parental smoking classification on the association between parental and adolescent smoking. Addict. Behav. 15 (1990) 413-422
16. 3H]Thymidine-radiographic studies of neurogenesis in the rat olfactory bulb. Exp. Brain Res. 50 (1983) 329-340
17. Bayer S.A., Yackel J.W., and Puri P.S. Neurons in the rat dentate gyrus granular layer substantially increase during juvenile and adult life. Science 216 (1982) 890-892
18. Bell G.L., and Lau K. Perinatal and neonatal issues of substance abuse. Pediatr. Clin. North Am. 42 (1995) 261-281
19. Benowitz N.L., and Dempsey D.A. Pharmacotherapy for smoking cessation during pregnancy. Nicotine Tob. Res. 6 (2004) S189-S202
20. Benowitz N.L., Porchet H., and Jacob III P. In: Wonnacott S., Russell M.A.H., and Stolerman I.P. (Eds). Pharmacokinetics, Metabolism, and Pharmacodynamics of Nicotine (1990), Nicotine Psychopharmacology Oxford Press, New York 112-157
21. Berger F., Gage F.H., and Vijayaraghavan S. Nicotinic receptor-induced apoptotic cell death of hippocampal progenitor cells. J. Neurosci. 18 (1998) 6871-6881
22. Brezun J.M., and Daszuta A. Depletion in serotonin decreases neurogenesis in the dentate gyrus and the subventricular zone of adult rats. Neuroscience 89 (1999) 999-1002
23. Britton A.F., Vann R.E., and Robinson S.E. Perinatal nicotine exposure eliminates peak in nicotinic acetylcholine receptor response in adolescent rats. J. Pharmacol. Exp. Ther. 320 (2007) 871-876
24. Burguet A., Kaminski M., Truffert P., Menget A., Marpeau L., Voyer M., Roze J.C., Escande B., Cambonie G., Hascoet J.M., Grandjean H., Breart G., Larroque B., and Epipage Study G. Does smoking in pregnancy modify the impact of antenatal steroids on neonatal respiratory distress syndrome? Results of the Epipage study. Arch. Dis. Child. 90 (2005) F41-F45
25. Butler N.R., and Goldstein H. Smoking in pregnancy and subsequent child development. Br. Med. J. 4 (1973) 573-574
26. 3H](-)nicotine binding sites in fetal human brain. Brain Res. 475 (1988) 1-7
27. Campbell A.J., Galland B.C., Bolton D.P.G., Taylor B.J., Sayers R.M., and Williams S.M. Ventilatory responses to rebreathing in infants exposed to maternal smoking. Acta Pædiatr. 90 (2001) 793-800
28. Centers for Disease Control and Prevention, Smoking during pregnancy - United States, 1990-2002, Morbid Mortal Wkly Rpt 53 (2004) 911-915.
29. Centers for Disease Control and Prevention, Tobacco use among high school students - United States, 1997, Morbid Mortal Wkly Rpt 47 (1998) 229-233.
30. Centers for Disease Control and Prevention, Trends in cigarette smoking among high school students: United States, 1991-1999, Morbid Mortal Wkly Rpt 49 (2000) 755-758.
31. Cepeda-Benito A., Reynoso J.T., and Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J. Consult. Clin. Psychol. 72 (2004) 712-722
32. Chassin L., Presson C.C., Rose J.S., Sherman S.J., and Prost J. Parental smoking cessation and adolescent smoking. J. Pediatr. Psychol. 27 (2002) 495-496
33. Chen J., and Millar W.J. Age of smoking inititation: implications for quitting. Health Rep. 9 (1998) 39-46
34. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine Tob. Res. 6 (2004) S125-S140
35. Colby S.M., Tiffany S.T., Shiffman S., and Niaura R.S. Are adolescent smokers dependent on nicotine? A review of the evidence. Drug Alcohol Depend. 59 (2000) S83-S95
36. Coleman T., Antoniak M., Britton J., Thornton J., Lewis S., and Watts K. Recruiting pregnant smokers for a placebo-randomised controlled trial of nicotine replacement therapy. BMC Health Serv. Res. 4 (2004) 29
37. Coleman T., Thornton J., Britton J., Lewis S., Watts K., Coughtrie M.W.H., Mannion C., Marlow N., and Godfrey C. Protocol for the smoking, nicotine and pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Serv. Res. 7 (2007) 2
38. Collins S.L., Wade D., Ledon J., and Izenwasser S. Neurochemical alterations produced by daily nicotine exposure in periadolescent vs. adult male rats. Eur. J. Pharmacol. 502 (2004) 75-85
39. Cornelius M.D., Leech S.L., Goldschmidt L., and Day N.L. Prenatal tobacco exposure: is it a risk factor for early tobacco experimentation?. Nicotine Tob. Res. 2 (2000) 45-52
40. Cornelius M.D., Ryan C.M., Day N.L., Goldschmidt L., and Willford J.A. Prenatal tobacco effects on neuropsychological outcomes among preadolescents. J. Dev. Behav. Pediatr. 22 (2001) 217-225
41. Cutler A.R., Wilkerson A.E., Gingras J.L., and Levin E.D. Prenatal cocaine and/or nicotine exposure in rats: preliminary findings on long-term cognitive outcome and genital development at birth. Neurotoxicol. Teratol. 18 (1996) 635-643
42. Day N.L., Richardson G.A., Goldschmidt L., and Cornelius M.D. Effects of prenatal tobacco exposure on preschoolers' behavior. J. Dev. Behav. Pediatr. 21 (2000) 180-188
43. DiFranza J.R., and Lew R.A. Effect of maternal cigarette smoking on pregnancy complications and Sudden Infant Death Syndrome. J. Family Pract. 40 (1995) 385-394
44. DiFranza J.R., and Wellman R.J. A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature. Nicotine. Tob. Res. 7 (2005) 9-26
45. DiFranza J.R., Rigotti N.A., McNeill A.D., Ockene J.K., Savageau J.A., St. Cyr D., and Coleman M. Initial symptoms of nicotine dependence in adolescents. Tob. Control 9 (2000) 313-319
46. DiFranza J.R., Savageau J.A., Fletcher K., Ockene J.K., Rigotti N.A., McNeill A.D., Coleman M., and Wood C. Measuring the loss of autonomy over nicotine use in adolescents: the DANDY (development and assessment of nicotine dependence in youths) study. Arch. Pediatr. Adolesc. Med. 156 (2002) 397-403
47. DiFranza J.R., Savageau J.A., Rigotti N.A., Fletcher K., Ockene J.K., McNeill A.D., Coleman M., and Wood C. Development of symptoms of tobacco dependence in youths: 30-month follow-up data from the DANDY study. Tob. Control 11 (2002) 228-235
48. DiFranza J.R., Aligne C.A., and Weitzman M. Prenatal and postnatal environmental tobacco smoke exposure and children's health. Pediatrics 113 (2004) 1007-1015
49. Dunn H.G., and McBurney A.K. Cigarette smoking and the fetus and child. Pediatrics 60 (1977) 772
50. Durant R.H., Rome E.S., Rich M., Allred E., Emans S.J., and Woods E.R. Tobacco and alcohol use behaviors portrayed in music videos: a content analysis. Am. J. Public Health 87 (1997) 1131-1135
51. Elliott B.M., Faraday M.M., Phillips J.M., and Grunberg N.E. Adolescent and adult female rats differ in sensitivity to nicotine's activity effects. Pharmacol. Biochem. Behav. 80 (2005) 567-575
52. Elsenbruch S., Benson S., Rucke M., Rose M., Dudenhausen J., Pincus-Knackstedt M.K., Klapp B.F., and Arck P.C. Social support during pregnancy: effects on maternal depressive symptoms, smoking and pregnancy outcome. Hum. Reprod. 22 (2007) 869-877
53. Eppolito A.K., and Smith R.F. Long-term behavioral and developmental consequences of pre- and perinatal nicotine. Pharmacol. Biochem. Behav. 85 (2006) 835-841
54. Falk L., Nordberg A., Seiger A., Kjaeldgaard A., and Hellstrom-Lindahl E. Smoking during early pregnancy affects the expression pattern of both nicotinic and muscarinic acetylcholine receptors in human first trimester brainstem and cerebellum. Neuroscience 132 (2005) 389-397
55. Faraday M.M., Elliott B.M., and Grunberg N.E. Adult vs. adolescent rats differ in biobehavioral responses to chronic nicotine administration. Pharmacol. Biochem. Behav. 70 (2001) 475-489
56. Fewell J.E. Protective responses of the newborn to hypoxia. Respir. Physiol. Neurobiol. 149 (2005) 243-255
57. Gao Y.J., Holloway A.C., Zeng Z.H., Lim G.E., Petrik J.J., Foster W.G., and Lee R.M. Prenatal exposure to nicotine causes postnatal obesity and altered perivascular adipose tissue function. Obes. Res. 13 (2005) 687-692
58. Ginzel K.H. Tobacco industry conduct: an analysis of selected issues. Tob. Prod. Litig. Report. 13.1 (1998)
59. Ginzel K.H., Maritz G.S., Marks D.F., Neuberger M., Pauly J.R., Polito J.R., Schulte-Hermann R., and Slotkin T.A. Nicotine for the fetus, the infant and the adolescent?. J. Health Psychol. 12 (2007) 215-224
60. Goldstein A., Aronow L., and Kalman S.M. Principles of Drug Action: The Basis of Pharmacology. Second ed., (1974), John Wiley & Sons, New York
61. Golub M.S., Slotkin T.A., and Pinkerton K.E. Visual recognition memory and auditory brainstem response in infant rhesus monkeys exposed perinatally to environmental tobacco smoke. Brain Res. 1151 (2007) 102-106
62. Goodman E., and Capitman J. Depressive symptoms and cigarette smoking among teens. Pediatrics 106 (2000) 748-755
63. Gospe S.M., Zhou S.S., and Pinkerton K.E. Effects of environmental tobacco smoke exposure in utero and/or postnatally on brain development. Pediatr. Res. 39 (1996) 494-498
64. Graff J.C., Murphy L., Ekvall S., and Gagnon M. In-home toxic chemical exposures and children with intellectual and developmental disabilities. Pediatr. Nursing 32 (2006) 596-603
65. Gray N., Henningfield J.E., Benowitz N.L., Connolly G.N., Dresler C., Fagerstrom K., Jarvis M.J., and Boyle P. Toward a comprehensive long term nicotine policy. Tob. Control 14 (2005) 161-165
66. Habek D., Habek J.C., Ivanisevic M., and Djelmis J. Fetal tobacco syndrome and perinatal outcome. Fetal Diagn. Ther. 17 (2002) 367-371
67. Hafstrom O., Milerad J., and Sundell H.W. Altered breathing pattern after prenatal nicotine exposure in the young lamb. Am. J. Respir. Crit. Care Med. 166 (2002) 92-97
68. 3H]nicotine binding in the fetal brain. Int. J. Dev. Neurosci. 3 (1985) 567-571
69. Hellstrom-Lindahl E., and Nordberg A. Smoking during pregnancy: a way to transfer the addiction to the next generation?. Respiration 69 (2002) 289-293
70. Hockertz S., Emmendorffer A., Scherer G., Ruppert T., Daube H., Tricker A.R., and Adlkoker F. Acute effects of smoking and high experimental exposure to environmental tobacco smoke (ETS) on the immune system. Cell Biol. Toxicol. 10 (1994) 177-190
71. Hong T., and Cody M.J. Presence of pro-tobacco messages on the Web. J. Health Commun. 7 (2002) 273-307
72. Horne R.S., Franco P., Adamson T.M., Groswasser J., and Kahn A. Influences of maternal cigarette smoking on infant arousability. Early Hum. Dev. 79 (2004) 49-58
73. Horne R.S., Parslow P.M., and Harding R. Postnatal development of ventilatory and arousal responses to hypoxia in human infants. Respir. Physiol. Neurobiol. 149 (2005) 257-271
74. Huang R.C., Burke V., Newnham J.P., Stanley F.J., Kendall G.E., Landau L.I., Oddy W.H., Blake K.V., Palmer L.J., and Beilin L.J. Perinatal and childhood origins of cardiovascular disease. Int. J. Obes. 31 (2007) 236-244
75. Hurt R.D., Croghan G.A., Beede S.D., Wolter T.D., Croghan I.T., and Patten C.A. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Arch. Pediatr. Adolesc. Med. 154 (2000) 31-37
76. Hussein J., Farkas S., MacKinnon Y., Ariano R.E., Sitar D.S., and Hasan S.U. Nicotine dose-concentration relationship and pregnancy outcomes in rat: biologic plausibility and implications for future research. Toxicol. Appl. Pharmacol. 218 (2007) 1-10
77. Huttenlocher P.R. Morphometric study of human cerebral cortex development. Neuropsychologia 28 (1990) 517-527
78. Indredavik M.S., Brubakk A.M., Romundstad P., and Vik T. Prenatal smoking exposure and psychiatric symptoms in adolescence. Acta Pædiatr. 96 (2007) 377-382
79. Jacobs B.L., van Praag H., and Gage F.H. Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol. Psychiatry 5 (2000) 262-269
80. Jacobsen L.K., Krystal J.H., Mencl W.E., Westerveld M., Frost S.J., and Pugh K.R. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol. Psychiatry 57 (2005) 56-66
81. Jacobsen L.K., Pugh K.R., Constable R.T., Westerveld M., and Mencl W.E. Functional correlates of verbal memory deficits emerging during nicotine withdrawal in abstinent adolescent cannabis users. Biol. Psychiatry 61 (2007) 31-40
82. L.K. Jacobsen, T.A. Slotkin, W.E. Mencl, S.J. Frost, K.R. Pugh, Gender specific effects of prenatal and adolescent exposure to tobacco smoke on auditory and visual attention, Neuropsychopharmacology (2007) in press.
83. Jacobsen L.K., Slotkin T.A., Westerveld M., Mencl W.E., and Pugh K.R. Visuospatial memory deficits during nicotine withdrawal in adolescents with prenatal exposure to active maternal smoking. Neuropsychopharmacology 31 (2006) 1550-1561
84. Janson A.M., Fuxe K., Agnati L.F., Kitayama I., Harfstrand A., Andersson K., and Goldstein M. Chronic nicotine treatment counteracts the disappearance of tyrosine-hydroxylase-immunoreactive nerve cell bodies, dendrites and terminals in the mesostriatal dopamine system of the male rat after partial hemitransection. Brain Res. 455 (1988) 332-345
85. Jha P., Ranson M.K., Nguyen S.N., and Yach D. Estimates of global and regional smoking prevalence in 1995, by age and sex. Am. J. Pub. Health 92 (2002) 1002-1006
86. Johnson J.D., Houchens D.P., Kluwe W.M., Craig D.K., and Fisher G.L. Effect of mainstream and sidestream tobacco smoke on the immune system in animals and humans: a review. Toxicology 20 (1990) 364-395
87. Kandel D.B., Wu P., and Davies M. Maternal smoking during pregnancy and smoking by adolescent daughters. Am. J. Pub. Health 84 (1994) 1407-1413
88. Kaneko S., Maeda T., Kume T., Kochiyama H., Akaike A., Shimohama S., and Kimura J. Nicotine protects cultured cortical neurons against glutamate-induced cytotoxicity via α7-neuronal receptors and neuronal CNS receptors. Brain Res. 765 (1997) 135-140
89. Kapur B., Hackman R., Selby P., Klein J., and Koren G. Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Curr. Ther. Res. - Clin. Exp. 62 (2001) 274-278
90. Kelley B.M., and Middaugh L.D. Periadolescent nicotine exposure reduces cocaine reward in adult mice. J. Addict. Dis. 18 (1999) 27-39
91. Klein L.C. Effects of adolescent nicotine exposure on opioid consumption and neuroendocrine responses in adult male and female rats. Exp. Clin. Psychopharmacol. 9 (2001) 251-261
92. Klein L.C., Stine M.M., Pfaff D.W., and Vandenbergh D.J. Maternal nicotine exposure increases nicotine preference in periadolescent male but not female C57B1/6J mice. Nicotine Tob. Res. 5 (2003) 117-124
93. Klerman L.V. Protecting children: reducing their environmental tobacco smoke exposure. Nicotine Tob. Res. 6 (2004) S239-S252
94. Klesges L.M., Johnson K.C., Somes G., Zbikowski S., and Robinson L. Use of nicotine replacement therapy in adolescent smokers and nonsmokers. Arch. Pediatr. Adolesc. Med. 157 (2003) 517-522
95. Lauder J.M. Roles for neurotransmitters in development: possible interaction with drugs during the fetal and neonatal periods. In: Marois M. (Ed). Prevention of Physical and Mental Congenital Defects (1985), Alan R. Liss, New York 375-380
96. Leary S.D., Smith G.D., Rogers I.S., Reilly J.J., Wells J.C.K., and Ness A.R. Smoking during pregnancy and offspring fat and lean mass in childhood. Obesity 14 (2006) 2284-2293
97. Lefkowitz M.M. Smoking during pregnancy: long-term effects on the offspring. Dev. Psychol. 17 (1981) 192-194
98. Levin E.D. Persisting effects of chronic adolescent nicotine administration on radial-arm maze learning and response to nicotinic challenges. Neurotoxicol. Teratol. 21 (1999) 338
99. Levin E.D., and Slotkin T.A. Developmental neurotoxicity of nicotine. In: Slikker W., and Chang L.W. (Eds). Handbook of Developmental Neurotoxicology (1998), Academic Press, San Diego 587-615
100. Levin E.D., Briggs S.J., Christopher N.C., and Rose J.E. Prenatal nicotine exposure and cognitive performance in rats. Neurotoxicol. Teratol. 15 (1993) 251-260
101. Levin E.D., Wilkerson A., Jones J.P., Christopher N.C., and Briggs S.J. Prenatal nicotine effects on memory in rats: pharmacological and behavioral challenges. Dev. Brain Res. 97 (1996) 207-215
102. Levin E.D., Rezvani A.H., Montoya D., Rose J.E., and Swartzwelder H.S. Adolescent-onset nicotine self-administration modeled in female rats. Psychopharmacology 169 (2003) 141-149
103. Levin E.D., Lawrence S., Petro A., Horton K., Seidler F.J., and Slotkin T.A. Increased nicotine self-administration following prenatal exposure in female rats. Pharmacol. Biochem. Behav. 85 (2006) 669-674
104. Levin E.D., Lawrence S., Petro A., Horton K., Seidler F.J., and Slotkin T.A. Adolescent vs. adult-onset nicotine self-administration in male rats: duration of effect and differential nicotinic receptor correlates. Neurotoxicol. Teratol. 29 (2007) 458-465
105. Liang K., Poytress B.S., Chen Y., Leslie F.M., Weinberger N.M., and Metherate R. Neonatal nicotine exposure impairs nicotinic enhancement of central auditory processing and auditory learning in adult rats. Eur. J. Neurosci. 24 (2006) 857-866
106. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., and Widmer H.R. Prenatal adverse effects of nicotine on the developing brain. Prog. Brain Res. 73 (1988) 137-157
107. Luck W., Nau H., Hansen R., and Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev. Pharmacol. Ther. 8 (1985) 384-395
108. Maes M., and Meltzer H. The serotonin hypothesis of major depression. In: Bloom F.E., Kupfer D.J., Bunney B.S., Ciaranello R.D., Davis K.L., Koob G.F., Meltzer H.Y., Schuster C.R., Shader R.I., and Watson S.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, New York 933-944
109. Makin J., Fried P.A., and Watkinson B. A comparison of active and passive smoking during pregnancy: long-term effects. Neurotoxicol. Teratol. 13 (1991) 5-12
110. Marco E.M., Llorente R., Moreno E., Biscaia J.M., Guaza C., and Viveros M.P. Adolescent exposure to nicotine modifies acute functional responses to cannabinoid agonists in rats. Behav. Brain Res. 172 (2006) 46-53
111. Maritz G.S. Maternal nicotine exposure during gestation and lactation of rats induce microscopic emphysema in the offspring. Exp. Lung Res. 28 (2002) 391-403
112. Martin J.C., and Becker R.F. The effects of maternal nicotine absorption or hypoxic episodes upon appetitive behavior of rat offspring. Dev. Psychobiol. 4 (1971) 133-147
113. Martin J.C., and Becker R.F. The effects of nicotine administration in utero upon activity in the rat. Psychon. Sci. 19 (1970) 59-60
114. Martini S., Wagner F.A., and Anthony J.C. The association of tobacco smoking and depression in adolescence: evidence from the United States. Subst. Use Misuse 37 (2002) 1853-1867
115. 3H](-)nicotine label the same recognition site in rat brain. Mol. Pharmacol. 31 (1987) 169-174
116. Matthews D.A., Nadler J.V., Lynch G.S., and Cotman C.W. Development of cholinergic innervation in the hippocampal formation of the rat. Dev. Biol. 36 (1974) 130-141
117. McAllister-Sistilli C.G., Caggiula A.R., Knopf S., Rose C.A., Miller A.L., and Donny E.C. The effects of nicotine on the immune system. Psychoneuroendocrinology 23 (1998) 175-187
118. McEwen B.S. Plasticity of the hippocampus: adaptation to chronic stress and allostatic load. Ann. NY. Acad. Sci. 933 (2001) 265-277
119. McEwen B.S. Sex, stress and the hippocampus: allostasis, allostatic load and the aging process. Neurobiol. Aging 23 (2002) 921-939
120. McQuown S.C., Belluzzi J.D., and Leslie F.M. Low dose nicotine treatment during early adolescence increases subsequent cocaine reward. Neurotoxicol. Teratol. 29 (2007) 66-73
121. Milerad J., and Sundell H. Nicotine exposure and the risk of SIDS. Acta Pædiat. Suppl. 389 (1993) 70-72
122. Milerad J., Larsson H., Lin J., and Sundell H.W. Nicotine attenuates the ventilatory response to hypoxia in the developing lamb. Pediatr. Res. 37 (1995) 652-660
123. Moolchan E.T., Robinson M.L., Ernst M., Cadet J.L., Pickworth W.B., Heishman S.J., and Schroeder J.R. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics 115 (2005) e407-e414
124. Morales-Suarez-Varela M.M., Bille C., Christensen K., and Olsen J. Smoking habits, nicotine use, and congenital malformations. Obstet. Gynecol. 107 (2006) 51-57
125. Murrin L.C., Ferrer J.R., Wanyun Z., and Haley N.J. Nicotine administration to rats: methodological considerations. Life Sci. 40 (1987) 1699-1708
126. 3H-nicotine receptor binding in the Sudden Infant Death Syndrome. J. Neuropathol. Exp. Neurol. 57 (1998) 1018-1025
127. Nadler J.V., Matthews D.A., Cotman C.W., and Lynch G.S. Development of cholinergic innervation in the hippocampal formation of the rat. II. Quantitative changes in choline acetyltransferase and acetylcholinesterase activities. Dev. Biol. 36 (1974) 142-154
128. 3H]nicotine binding sites in rat brain regions: an autoradiographic study. Dev. Brain Res. 68 (1992) 163-174
129. Naeye R.L. Cognitive and behavioral abnormalities in children whose mothers smoked cigarettes during pregnancy. J. Dev. Behav. Pediatr. 13 (1992) 425-428
130. Naeye R.L. Effects of maternal cigarette smoking on the fetus and placenta. Br. J. Obstet. Gynæcol. 85 (1978) 732-737
131. Naeye R.L., and Peters E.C. Mental development of children whose mothers smoked during pregnancy. Obstet. Gynecol. 64 (1984) 601-607
132. Náquira D., and Arqueros L. Water intake in rats affected by addition of nicotine to drinking water. Acta Physiol. Lat. Am. 28 (1977) 73-76
133. Nasrat H.A., Al-Hachim G.M., and Mahmood F.A. Perinatal effects of nicotine. Biol. Neonate 49 (1986) 8-14
134. National Institute on Drug Abuse. Nicotine Addiction (1998), NIH Publication Number 98-4342, Washington, DC
135. Navarro H.A., Seidler F.J., Whitmore W.L., and Slotkin T.A. Prenatal exposure to nicotine via maternal infusions: effects on development of catecholamine systems. J. Pharmacol. Exp. Ther. 244 (1988) 940-944
136. Navarro H.A., Seidler F.J., Schwartz R.D., Baker F.E., Dobbins S.S., and Slotkin T.A. Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res. Bull. 23 (1989) 187-192
137. Navarro H.A., Seidler F.J., Eylers J.P., Baker F.E., Dobbins S.S., Lappi S.E., and Slotkin T.A. Effects of prenatal nicotine exposure on development of central and peripheral cholinergic neurotransmitter systems. Evidence for cholinergic trophic influences in developing brain. J. Pharmacol. Exp. Ther. 251 (1989) 894-900
138. Navarro H.A., Mills E., Seidler F.J., Baker F.E., Lappi S.E., Tayyeb M.I., Spencer J.R., and Slotkin T.A. Prenatal nicotine exposure impairs β-adrenergic function: persistent chronotropic subsensitivity despite recovery from deficits in receptor binding. Brain Res. Bull. 25 (1990) 233-237
139. 1-receptors. Res. Comm. Substance. Abuse. 11 (1990) 95-103
140. Navarro H.A., Basta P.V., Seidler F.J., and Slotkin T.A. Adolescent nicotine: deficits in immune function. Dev. Brain Res. 130 (2001) 253-256
141. Navarro H.A., Basta P.V., Seidler F.J., and Slotkin T.A. Short-term adolescent nicotine exposure in rats elicits immediate and delayed deficits in T-lymphocyte function: critical periods, patterns of exposure, dose thresholds. Nicotine Tob. Res. 5 (2003) 859-868
142. Nelson D.E., Giovino G.A., Shopland D.R., Mowery P.D., Mills S.L., and Eriksen M.P. Trends in cigarette smoking among US adolescents, 1974 through 1991. Am. J. Pub. Health 85 (1995) 34-40
143. Nelson E., Goubet-Wiemers C., Guo Y.J., and Jodscheit K. Maternal passive smoking during pregnancy and foetal developmental toxicity. Part 2: histological changes. Human Exp. Toxicol. 18 (1999) 257-264
144. Niaura R., Bock B., Lloyd E.E., Brown R., Lipsitt L.P., and Buka S. Maternal transmission of nicotine dependence: psychiatric, neurocognitive and prenatal factors. Am. J. Addict. 10 (2001) 16-29
145. Nieburg P., Marks J.S., McLaren N.M., and Remington P.L. The fetal tobacco syndrome. JAMA 253 (1985) 2998-2999
146. O'Dell L.E., Bruijnzeel A.W., Ghozland S., Markou A., and Koob G.F. Nicotine withdrawal in adolescent and adult rats. Ann. NY Acad. Sci. 1021 (2004) 167-174
147. O'Dell L.E., Bruijnzeel A.W., Smith R.T., Parsons L.H., Merves M.L., Goldberger B.A., Richardson H.N., Koob G.F., and Markou A. Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction. Psychopharmacology 186 (2006) 612-619
148. O'Dell L.E., Torres O.V., Natividad L.A., and Tejeda H.A. Adolescent nicotine exposure produces less affective measures of withdrawal relative to adult nicotine exposure in male rats. Neurotoxicol. Teratol. 29 (2007) 17-22
149. Oken E., Huh S.Y., Taveras E.M., Rich-Edwards J.W., and Gillman M.W. Associations of maternal prenatal smoking with child adiposity and blood pressure. Obes. Res. 13 (2005) 2021-2028
150. Oncken C.A., Henryi K.M., Campbell W.A., Kuhn C.M., Van Kirk J., Slotkin T.A., and Kranzler H.R. The effect of maternal smoking on fetal catecholamine levels at birth. Pediatr. Res. 53 (2003) 119-124
151. Oncken C., McKee S., Krishnan-Sarin S., O'Malley S., and Mazure C. Gender effects of reported in utero tobacco exposure on smoking initiation, progression and nicotine dependence in adult offspring. Nicotine Tob. Res. 6 (2004) 829-833
152. Orlebeke J.F., Knol D.L., and Verhulst F.C. Child behavior problems increased by maternal smoking during pregnancy. Arch. Environ. Health 54 (1999) 15-19
153. Ostrea E.M., Knapp D.K., Romero A., Montes M., and Ostrea A.R. Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. J. Pediatr. 124 (1994) 471-476
154. Owman C., Fuxe K., Janson A.M., and Kahrstrom J. Chronic nicotine treatment eliminates asymmetry in striatal glucose utilization following unilateral transection of the mesostriatal dopamine pathway in rats. Neurosci. Lett. 102 (1989) 279-283
155. Patten C.A., Choi W.S., Gillin J.C., and Pierce J.P. Depressive symptoms and cigarette smoking predict development and persistence of sleep problems in US adolescents. Pediatrics 106 (2000) 50-58
156. Pauly J.R., Sparks J.A., Hauser K.F., and Pauly T.H. In utero nicotine exposure causes persistent, gender-dependant changes in locomotor activity and sensitivity to nicotine in C57Bl/6 mice. Int. J. Dev. Neurosci. 22 (2004) 329-337
157. Perera F.P., Rauh V., Whyatt R.M., Tang D., Tsai W.Y., Bernert J.T., Tu Y.H., Andrews H., Barr D.B., Camann D.E., Diaz D., Dietrich J., Reyes A., and Kinney P.L. A summary of recent findings on birth outcomes and developmental effects of prenatal ETS, PAH, and pesticide exposures. Neurotoxicology 26 (2005) 573-587
158. Perry D.C., Davila-Garcia M.I., Stockmeier C.A., and Kellar K.J. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J. Pharmacol. Exp. Ther. 289 (1999) 1545-1552
159. Pickett K.E., Wakschlag L.S., Dai L., and Leventhal B.L. Fluctuations of maternal smoking during pregnancy. Obstet. Gynecol. 101 (2003) 140-147
160. Pierce J.P., and Gilpin E. How long will today's new adolescent smoker be addicted to cigarettes?. Am. J. Pub. Health 86 (1996) 253-256
161. Pinkerton K.E., and Joad J.P. The mammalian respiratory system and critical windows of exposure for children's health. Environ. Health Perspect. 108 (2000) S457-S462
162. Piquero A.R., Gibson C.L., Tibbetts S.G., Turner M.G., and Katz S.H. Maternal cigarette smoking during pregnancy and life-course-persistent offending. Int. J. Offender Ther. Comp. Criminol. 46 (2002) 231-248
163. Polanska K., Hanke W., Ronchetti R., van den Hazel P., Zuurbier M., Koppe J.G., and Bartonova A. Environmental tobacco smoke exposure and children's health. Acta Pædiatr. Supp. 95 (2006) 86-92
164. Pollak K.I., Oncken C.A., Lipkus I.M., Lyna P., Swamy G.K., Pletsch P.K., Peterson B.L., Heine R.P., Namenek Brouwer R.J., Fish L., and Myers E.R. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. Am. J. Prev. Med. 33 (2007) 297-305
165. Power C., and Jefferis B.J. Fetal environment and subsequent obesity: a study of maternal smoking. Int. J. Epidemiol. 31 (2002) 413-419
166. Proskocil B.J., Sekhon H.S., Clark J.A., Lupo S.L., Jia Y., Hull W.M., Whitsett J.A., Starcher B.C., and Spindel E.R. Vitamin C prevents the effects of prenatal nicotine on pulmonary function in newborn monkeys. Am. J. Respir. Crit. Care Med. 171 (2005) 1032-1039
167. Rasanen P., Hakko H., Isohanni M., Hodgins S., Jarvelin M.R., and Tiihonen J. Maternal smoking during pregnancy and risk of criminal behavior among adult male offspring in the northern Finland 1966 birth cohort. Am. J. Psychiatry 156 (1999) 857-862
168. Riala K., Alaraisanen A., Taanila A., Hakko H., Timonen M., and Rasanen P. Regular daily smoking among 14-year-old adolescents increases the subsequent risk for suicide: the Northern Finland 1966 Birth Cohort Study. J. Clin. Psychiatry 68 (2007) 775-780
169. Ribary U., and Lichtensteiger W. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female
170. Roberts K.H., Munafò M.R., Rodriguez D., Drury M., Murphy M.F.G., Neale R.E., and Nettle D. Longitudinal analysis of the effect of prenatal nicotine exposure on subsequent smoking behavior of offspring. Nicotine Tob. Res. 7 (2005) 801-808
171. Roy T.S., and Sabherwal U. Effects of gestational nicotine exposure on hippocampal morphology. Neurotoxicol. Teratol. 20 (1998) 465-473
172. Roy T.S., and Sabherwal U. Effects of prenatal nicotine exposure on the morphogenesis of somatosensory cortex. Neurotoxicol. Teratol. 16 (1994) 411-421
173. Roy T.S., Andrews J.E., Seidler F.J., and Slotkin T.A. Nicotine evokes cell death in embryonic rat brain during neurulation. J. Pharmacol. Exp. Ther. 287 (1998) 1135-1144
174. Roy T.S., Seidler F.J., and Slotkin T.A. Prenatal nicotine exposure evokes alterations of cell structure in hippocampus and somatosensory cortex. J. Pharmacol. Exp. Ther. 300 (2002) 124-133
175. Russell T.V., Crawford M.A., and Woodby L.L. Measurements for active cigarette smoke exposure in prevalence and cessation studies: why simply asking pregnant women isn't enough. Nicotine Tob. Res. 6 (2004) S141-S151
176. Salin-Pascual R.J., De la Fuente J.R., Galicia-Polo L., and Drucker-Colin R. Effects of transdermal nicotine on mood and sleep in nonsmoking major depressed patients. Psychopharmacology 121 (1995) 476-479
177. Salsberry P.J., and Reagan P.B. Dynamics of early childhood overweight. Pediatrics 116 (2005) 1329-1338
178. Sandberg K.L., Poole S.D., Hamdan A., Minton P.A., and Sundell H.W. Prenatal nicotine exposure transiently alters the lung mechanical response to hypoxia in young lambs. Respir. Physiol. Neurobiol. 156 (2007) 283-292
179. Sansores R.H., Giraldo-Buitrago G., Reddy C., and Ramirez-Venegas A. Sexual content of advertisements and the smoking process in adolescents. Chest 121 (2002) 2016-2022
180. Sarasin A., Schlumpf M., Müller M., Fleischmann I., Lauber M.E., and Lichtensteiger W. Adrenal-mediated rather than direct effects of nicotine as a basis of altered sex steroid synthesis in fetal and neonatal rat. Reprod. Toxicol. 17 (2003) 153-162
181. Sawnani H., Jackson T., Murphy T., Beckerman R., and Simakajornboon N. The effect of maternal smoking on respiratory and arousal patterns in preterm infants during sleep. Am. J. Resp. Crit. Care Med. 169 (2004) 733-738
182. Schneider A.S., Atluri P., Shen Q., Barnes W., Mah S.J., Stadfelt D., Goderie S.K., Temple S., and Fleck M.W. Functional nicotinic acetylcholine receptor expression on stem and progenitor cells of the early embryonic nervous system. Ann. NY Acad. Sci. 971 (2002) 135-138
183. Schroeder D.R., Ogburn Jr. P.L., Hurt R.D., Croghan I.T., Ramin K.D., Offord K.P., and Moyer T.P. Nicotine patch use in pregnant smokers: smoking abstinence and delivery outcomes. J. Maternal-Fetal. Neonat. Med. 11 (2002) 100-107
184. Seidler F.J., Levin E.D., Lappi S.E., and Slotkin T.A. Fetal nicotine exposure ablates the ability of postnatal nicotine challenge to release norepinephrine from rat brain regions. Dev. Brain Res. 69 (1992) 288-291
185. Sekhon H.S., Jia Y.B., Raab R., Kuryatov A., Pankow J.F., Whitsett J.A., Lindstrom J., and Spindel E.R. Prenatal nicotine increases pulmonary α7 nicotinic receptor expression and alters fetal lung development in monkeys. J. Clin. Invest. 103 (1999) 637-647
186. Shoaib M., and Stolerman I.P. Plasma nicotine and cotinine levels following intravenous nicotine self-administration in rats. Psychopharmacology 143 (1999) 318-321
187. Slawecki C.J., and Ehlers C.L. Lasting effects of adolescent nicotine exposure on the electroencephalogram, event related potentials, and locomotor activity in the rat. Dev. Brain Res. 138 (2002) 15-25
188. Slikker W., and Schwetz B.A. Childhood obesity: the possible role of maternal smoking and impact on public health. J. Child Health Care 1 (2003) 29-40
189. Slikker W., Xu Z.A., Levin E.D., and Slotkin T.A. Mode of action: disruption of brain cell replication, second messenger, and neurotransmitter systems during development leading to cognitive dysfunction - developmental neurotoxicity of nicotine. Crit. Rev. Toxicol. 35 (2005) 703-711
190. Slotkin T.A. Prenatal exposure to nicotine: what can we learn from animal models?. In: Zagon I.S., and Slotkin T.A. (Eds). Maternal Substance Abuse and the Developing Nervous System (1992), Academic Press, San Diego 97-124
191. Slotkin T.A. Fetal nicotine or cocaine exposure: which one is worse?. J. Pharmacol. Exp. Ther. 285 (1998) 931-945
192. Slotkin T.A. The impact of fetal nicotine exposure on nervous system development and its role in Sudden Infant Death Syndrome. In: Benowitz N.L. (Ed). Safety and Toxicity of Nicotine (1998), Oxford, New York 89-97
193. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ. Health Perspect. 107 suppl 1 (1999) 71-80
194. Slotkin T.A. Nicotine and the adolescent brain: insights from an animal model. Neurotoxicol. Teratol. 24 (2002) 369-384
195. Slotkin T.A. Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol. Appl. Pharmacol. 198 (2004) 132-151
196. Slotkin T.A., and Seidler F.J. A unique role for striatal serotonergic systems in the withdrawal from adolescent nicotine administration. Neurotoxicol. Teratol. 29 (2007) 10-16
197. Slotkin T.A., Greer N., Faust J., Cho H., and Seidler F.J. Effects of maternal nicotine injections on brain development in the rat: ornithine decarboxylase activity, nucleic acids and proteins in discrete brain regions. Brain Res. Bull. 17 (1986) 41-50
198. Slotkin T.A., Cho H., and Whitmore W.L. Effects of prenatal nicotine exposure on neuronal development: selective actions on central and peripheral catecholaminergic pathways. Brain Res. Bull. 18 (1987) 601-611
199. 3H]nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions. J. Pharmacol. Exp. Ther. 242 (1987) 232-237
200. Slotkin T.A., Orband-Miller L., Queen K.L., Whitmore W.L., and Seidler F.J. Effects of prenatal nicotine exposure on biochemical development of rat brain regions: maternal drug infusions via osmotic minipumps. J. Pharmacol. Exp. Ther. 240 (1987) 602-611
201. Slotkin T.A., Navarro H.A., McCook E.C., and Seidler F.J. Fetal nicotine exposure produces postnatal up-regulation of adenylate cyclase activity in peripheral tissues. Life Sci. 47 (1990) 1561-1567
202. Slotkin T.A., McCook E.C., Lappi S.E., and Seidler F.J. Altered development of basal and forskolin-stimulated adenylate cyclase activity in brain regions of rats exposed to nicotine prenatally. Dev. Brain Res. 68 (1992) 233-239
203. Slotkin T.A., Lappi S.E., and Seidler F.J. Impact of fetal nicotine exposure on development of rat brain regions: critical sensitive periods or effects of withdrawal?. Brain Res. Bull. 31 (1993) 319-328
204. Slotkin T.A., Lappi S.E., McCook E.C., Lorber B.A., and Seidler F.J. Loss of neonatal hypoxia tolerance after prenatal nicotine exposure: implications for Sudden Infant Death Syndrome. Brain Res. Bull. 38 (1995) 69-75
205. Slotkin T.A., McCook E.C., and Seidler F.J. Cryptic brain cell injury caused by fetal nicotine exposure is associated with persistent elevations of c-fos protooncogene expression. Brain Res. 750 (1997) 180-188
206. Slotkin T.A., Saleh J.L., McCook E.C., and Seidler F.J. Impaired cardiac function during postnatal hypoxia in rats exposed to nicotine prenatally: implications for perinatal morbidity and mortality, and for Sudden Infant Death Syndrome. Teratology 55 (1997) 177-184
207. Slotkin T.A., Epps T.A., Stenger M.L., Sawyer K.J., and Seidler F.J. Cholinergic receptors in heart and brainstem of rats exposed to nicotine during development: implications for hypoxia tolerance and perinatal mortality. Dev. Brain Res. 113 (1999) 1-12
208. Slotkin T.A., Pinkerton K.E., and Seidler F.J. Perinatal exposure to environmental tobacco smoke alters cell signaling in a primate model: autonomic receptors and the control of adenylyl cyclase activity in heart and lung. Dev. Brain Res. 124 (2000) 53-58
209. Slotkin T.A., Pinkerton K.E., Auman J.T., Qiao D., and Seidler F.J. Perinatal exposure to environmental tobacco smoke upregulates nicotinic cholinergic receptors in monkey brain. Dev. Brain Res. 133 (2002) 175-179
210. Slotkin T.A., Seidler F.J., Qiao D., Aldridge J.E., Tate C.A., Cousins M.M., Proskocil B.J., Sekhon H.S., Clark J.A., Lupo S.L., and Spindel E.R. Effects of prenatal nicotine exposure on primate brain development and attempted amelioration with supplemental choline or vitamin C: neurotransmitter receptors, cell signaling and cell development biomarkers in fetal brain regions of Rhesus monkeys. Neuropsychopharmacology 30 (2005) 129-144
211. Slotkin T.A., Pinkerton K.E., and Seidler F.J. Perinatal environmental tobacco smoke exposure in Rhesus monkeys: critical periods and regional selectivity for effects on brain cell development and lipid peroxidation. Environ. Health Perspect. 114 (2006) 34-39
212. Slotkin T.A., Pinkerton K.E., Tate C.A., and Seidler F.J. Alterations of serotonin synaptic proteins in brain regions of neonatal Rhesus monkeys exposed to perinatal environmental tobacco smoke. Brain Res. 1111 (2006) 30-35
213. Slotkin T.A., Tate C.A., Cousins M.M., and Seidler F.J. Prenatal nicotine exposure alters the response to subsequent nicotine administration and withdrawal in adolescence: serotonin receptors and cell signaling. Neuropsychopharmacology 31 (2006) 2462-2475
214. Slotkin T.A., MacKillop E.A., Rudder C.L., Ryde I.T., Tate C.A., and Seidler F.J. Permanent, sex-selective effects of prenatal or adolescent nicotine exposure, separately or sequentially, in rat brain regions: indices of cholinergic and serotonergic synaptic function, cell signaling, and neural cell number and size at six months of age. Neuropsychopharmacology 32 (2007) 1082-1097
215. Slotkin T.A., Ryde I.T., and Seidler F.J. Separate or sequential exposure to nicotine prenatally and in adulthood: persistent effects on acetylcholine systems in rat brain regions. Brain Res. Bull. 74 (2007) 91-103
216. Slotkin T.A., Ryde I.T., Tate C.A., and Seidler F.J. Lasting effects of nicotine treatment and withdrawal on serotonergic systems and cell signaling in rat brain regions: separate or sequential exposure during fetal development and adulthood. Brain Res. Bull. 73 (2007) 259-272
217. Steuber T.L., and Danner F.W. Adolescent smoking and depression: which comes first?. Addict. Behav. 31 (2006) 133-136
218. Subramaniam S., Srinivasan S., Bummer P.M., and Gairola C.G. Perinatal sidestream cigarette smoke exposure and the developing pulmonary surfactant system in rats. Human Exp. Toxicol. 18 (1999) 206-211
219. Szpir M. New thinking on neurodevelopment. Environ. Health Perspect. 114 (2006) A101-A107
220. Szpir M. Tracing the origins of autism: a spectrum of new studies. Environ. Health Perspect. 114 (2006) A412-A417
221. Tanapat P., Hastings N.B., Reeves A.J., and Gould E. Estrogen stimulates a transient increase in the number of new neurons in the dentate gyrus of the adult female rat. J. Neurosci. 19 (1999) 5792-5801
222. Thorndike A.N., Ferris T.G., Stafford R.S., and Rigotti N.A. Rates of US physicians counseling adolescents about smoking. J. Natl. Cancer Inst. 91 (1999) 1857-1862
223. Toschke A.M., Koletzko B., Slikker W., Hermann M., and von Kries R. Childhood obesity is associated with maternal smoking in pregnancy. Eur. J. Pediatr. 161 (2002) 445-448
224. Toschke A.M., Ehlin A.G., von Kries R., Ekbom A., and Montgomery S.M. Maternal smoking during pregnancy and appetite control in offspring. J. Perinatal. Med. 31 (2003) 251-256
225. Trauth J.A., Seidler F.J., McCook E.C., and Slotkin T.A. Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res. 851 (1999) 9-19
226. Trauth J.A., Seidler F.J., McCook E.C., and Slotkin T.A. Persistent c-fos induction by nicotine in developing rat brain regions: interaction with hypoxia. Pediatr. Res. 45 (1999) 38-45
227. Trauth J.A., McCook E.C., Seidler F.J., and Slotkin T.A. Modeling adolescent nicotine exposure: effects on cholinergic systems in rat brain regions. Brain Res. 873 (2000) 18-25
228. Trauth J.A., Seidler F.J., and Slotkin T.A. An animal model of adolescent nicotine exposure: effects on gene expression and macromolecular constituents in rat brain regions. Brain Res. 867 (2000) 29-39
229. Trauth J.A., Seidler F.J., and Slotkin T.A. Persistent and delayed behavioral changes after nicotine treatment in adolescent rats. Brain Res. 880 (2000) 167-172
230. Trauth J.A., Seidler F.J., Ali S.F., and Slotkin T.A. Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function. Brain Res. 892 (2001) 269-280
231. Tsoh J.Y., Humfleet G.L., Munoz R.F., Reus V.I., Hartz D.T., and Hall S.M. Development of major depression after treatment for smoking cessation. Am. J. Psychiat. 157 (2000) 368-374
232. Upadhyaya H.P., Deas D., Brady K.T., and Kruesi M. Cigarette smoking and psychiatric comorbidity in children and adolescents. J. Am. Acad. Child. Adolesc. Psychiat. 41 (2002) 1294-1305
233. U.S. Department of Health and Human Services. Women and Smoking: A Report of the Surgeon General, U.S. (2001), Department of Health and Human Services, Rockville MD
234. Varvarigou A.A., Petsali M., Vassilakos P., and Beratis N.G. Increased cortisol concentrations in the cord blood of newborns whose mothers smoked during pregnancy. J. Perinat. Med. 34 (2006) 466-470
235. von Kries R., Toschke A.M., Koletzko B., and Slikker Jr. W. Maternal smoking during pregnancy and childhood obesity. Am. J. Epidemiol. 156 (2002) 954-961
236. Wakschlag L.S., and Hans S.L. Maternal smoking during pregnancy and conduct problems in high-risk youth: a developmental framework. Dev. Psychopathol. 14 (2002) 351-369
237. Wakschlag L.S., Lahey B.B., Loeber R., Green S.M., Gordon R.A., and Leventhal B.L. Maternal smoking during pregnancy and the risk of conduct disorder in boys. Arch. Gen. Psychiat. 54 (1997) 670-676
238. Wakschlag L.S., Pickett K.E., Cook E., Benowitz N.L., and Leventhal B.L. Maternal smoking during pregnancy and severe antisocial behavior in offspring: a review. Am. J. Public Health 92 (2002) 966-974
239. Weitzman M., Byrd R.S., Aligne C.A., and Moss M. The effects of tobacco exposure on children's behavioral and cognitive functioning: implications for clinical and public health policy and future research. Neurotoxicol. Teratol. 24 (2002) 397-406
240. Whitaker-Azmitia P.M. Role of serotonin and other neurotransmitter receptors in brain development: basis for developmental pharmacology. Pharmacol. Rev. 43 (1991) 553-561
241. Wilmouth C.E., and Spear L.P. Withdrawal from chronic nicotine in adolescent and adult rats. Pharmacol. Biochem. Behav. 85 (2006) 648-657
242. Wisborg K., Henriksen T.B., Jespersen L.B., and Secher N.J. Nicotine patches for pregnant smokers: a randomized controlled study. Obstet. Gynecol. 96 (2000) 967-971
243. World Health Organization. Tobacco or Health: A Global Status Report (1997), World Health Organization, Geneva
244. Wu L.T., and Anthony J.C. Tobacco smoking and depressed mood in late childhood and early adolescence. Am. J. Public Health 89 (1999) 1837-1840
245. Xu Z., Seidler F.J., Ali S.F., Slikker W., and Slotkin T.A. Fetal and adolescent nicotine administration: effects on CNS serotonergic systems. Brain Res. 914 (2001) 166-178
246. Xu Z., Seidler F.J., Cousins M.M., Slikker W., and Slotkin T.A. Adolescent nicotine administration alters serotonin receptors and cell signaling mediated through adenylyl cyclase. Brain Res. 951 (2002) 280-292
247. Xu Z., Seidler F.J., Tate C.A., Garcia S.J., Slikker W., and Slotkin T.A. Sex-selective hippocampal alterations after adolescent nicotine administration: effects on neurospecific proteins. Nicotine Tob. Res. 5 (2003) 955-960
248. Yamashita H., and Nakamura S. Nicotine rescues PC12 cells from death induced by nerve growth factor deprivation. Neurosci. Lett. 213 (1996) 145-147
249. Yanai J. Neurobehavioral Teratology (1984), Elsevier, Amsterdam
250. Yanai J., Pick C.G., Rogel-Fuchs Y., and Zahalka E.A. Alterations in septohippocampal cholinergic receptors and related behavior after prenatal exposure to nicotine. Effects of Nicotine on Biological Systems (1991), Birkhäuser Verlag, Basel 401-406
251. Yanai J., Pick C.G., Rogel-Fuchs Y., and Zahalka E.A. Alterations in hippocampal cholinergic receptors and hippocampal behaviors after early exposure to nicotine. Brain Res. Bull. 29 (1992) 363-368
252. Yanai J., Vatury O., and Slotkin T.A. Cell signaling as a target and underlying mechanism for neurobehavioral teratogenesis. Ann. NY Acad. Sci. 965 (2002) 473-478
253. 3H]hemicholinium-3 binding. Neurotoxicol. Teratol. 14 (1992) 375-382
254. 1-receptors and their link to G-proteins. Neurotoxicol. Teratol. 15 (1993) 107-115
255. Zahalka E.A., Seidler F.J., Lappi S.E., Yanai J., and Slotkin T.A. Differential development of cholinergic nerve terminal markers in rat brain regions: Implications for nerve terminal density, impulse activity and specific gene expression. Brain Res. 601 (1993) 221-229